Keywords: hyun, dai, license, novastan, inj, mitsubishi, kasei

HYUN DAI TO LICENSE NOVASTAN INJ

Article | 07 June 1993

Print This

Mitsubishi Kasei has licensed its antithrombin drug Novastan Inj (argatroban) to Hyun Dai Pharmaceutical Industry of South Korea. Hyun Dai ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in